listened Comprehensive Notes on Non Self-Administered, Nonhormonal Contraception, and Pregnancy Termination
Digital Health and Contraceptive Mobile Applications
FDA Oversight of Mobile Medical Applications: * The FDA maintains oversight of software functions that meet the definition of a medical device. * The primary concern is functionality that could pose a risk to patient safety if it fails to function as intended. * Policy was last updated in September .
Natural Cycles (Cycle App): * FDA-approved for users years of age and older. * Requires an annual subscription and the use of a basal body temperature thermometer. * Efficacy Rates: * Typical Use: effective. * Perfect Use: effective. * Data Entry: Users record basal body temperature every morning. * Wearable Compatibility: NC Band, Oura Ring, Garmin Watch, and Apple Watch. * Output: Provides a daily fertility status.
Clue Birth Control (Cycle App): * Received FDA clearance in but has not yet fully launched as of the lecture data (Clue cycle tracking app is available). * Efficacy Rates: * Typical Use: effective. * Perfect Use: effective. * Criteria for Use: Users aged with cycles between days in length, with a variance of days or less. * Mechanism: Uses documentation of "cycle day " and does not appear to require basal body temperature monitoring.
Other Available Tracking Apps: * Ovia Health, Flo, MyFlo, MagicGirl (specifically designed for teens), Cycles, Eve by Glow, Glow, Apple Cycle Tracking, Spot On, and Period Tracker.
Lactic Acid, Citric Acid, and Potassium Bitartrate Vaginal Gel (Phexxi)
Overview: * Approved for on-demand pregnancy prevention in females of reproductive potential. * Product Content: Each single-dose ( grams) pre-filled applicator contains: * of lactic acid. * of citric acid. * of potassium bitartrate. * Administration: Administer one -gram dose immediately before or up to hour before each act of vaginal intercourse. * Mechanism of Action: Lowers vaginal pH to reduce sperm motility.
Efficacy and Safety: * Efficacy: Estimated Pearl Index (failures per women-years) is , which is approximately effective. * Compatibility: * Avoid use with vaginal rings. * Safe for use with condoms, diaphragms, and vaginal infection treatments. * Adverse Effects: Vaginal burning, itching, discomfort, hypersensitivity, and vaginal mycotic infections. * Serious Reports: Instances of cystitis and pyelonephritis have been reported.
Depot Medroxyprogesterone Acetate (DMPA) - Contraceptive Injection
Product Formulations: * Subcutaneous (SQ): administered every months ( weeks). * Intramuscular (IM): administered every months ( weeks). * CDC call in recommended making self-administered SQ options available.
Adverse Effects: * Menstrual Irregularities: Frequent breakthrough bleeding; of users become amenorrheic within year. * Weight Gain: Average of at year and at years. * General: Headache (), bloating, breast tenderness, mood changes, and decreased libido. * VTE Risk: Increased risk of Venous Thromboembolism () compared to Progestin-only Pills ().
Fertility Return: Delayed; median time to conception is months after the last injection (range of months).
Bone Health Warning: * Black Box Warning: Potential for decreased Bone Mineral Density (). * Loss of over years; loss increases with duration. * May not be completely reversible. * Recommendation: Not recommended for use longer than years unless necessary; supplement with Calcium and Vitamin D. * ACOG Position: Supports use years and states measurements are not necessary, as mostly recovers (though recovery at the hip/femoral neck in adolescents is a concern).
Non-Contraceptive Benefits: * Decreased risk of endometrial cancer. * reduction in seizures for women with epilepsy. * reduction in acute sickle cell crises (caution regarding possible risk). * Improved iron-deficiency anemia due to reduced menstrual cycles. * Effective regardless of weight or drug interactions.
Initiation Protocols: * Start if "reasonably certain" not pregnant. * Within 7 days of menses start: No backup needed. * After 7 days of menses start (or amenorrhea): Use backup for days. * Postpartum: Can start any time. No backup if < months, amenorrheic, and fully breastfeeding. Otherwise, backup for days if > days postpartum.
Dosing Windows: * Early: No limit. * Late: Up to weeks late ( weeks from last dose) requires no backup. * Over weeks late ( weeks): Requires backup for days and possible emergency contraception ().
Bleeding Management: * Rule out other causes first. * Treatment: for days during bleeding; low-dose or estrogen for days for heavy bleeding.
Long-Acting Reversible Contraceptives (LARCs) - Intrauterine Devices (IUDs)
Levonorgestrel (LNG) IUDs: * Skyla: LNG; lasts years. * Kyleena: LNG; lasts years. * Mirena: LNG; lasts years. * Liletta: LNG; lasts years.
Copper IUDs (Nonhormonal): * ParaGard: Copper T; lasts years. * Miudella: Copper T; lasts years.
Mechanisms of Action (MOA): * Inhibits fertilization via thickened cervical mucus and inhibited sperm function. * Endometrium suppression and weak foreign body reaction induction. * Ovulation is generally not inhibited (most cycles are ovulatory), though Mirena may inhibit some.
Efficacy: Highly efficacious with failure rates .
Placement and Timing: * Insert any time patient is reasonably certain not pregnant. * Copper IUD: No backup needed. * LNG IUD: Backup for first days if inserted days since menses began. * STD Screening: Do not delay for screening unless infection is highly likely. If an STD occurs while the IUD is in place, treat the STD; IUD removal is only considered if symptoms don't resolve in hours (CDC MEC Category ).
Adverse Effects: * Mild bleeding/cramping ( days); irregular breakthrough bleeding for months. * amenorrhea rate at year. * Expulsion risk: within days ; after day .
Long-Acting Reversible Contraceptives (LARCs) - Etonogestrel Implant
Nexplanon: * Etonogestrel single rod (matchstick-sized). * Implanted subdermally; effective for up to years. * Requires specific training for provider insertion and removal.
Initiation: * Within days of menses start: No backup. * After days (or amenorrhea): Backup for days. * Postpartum: Same rules as DMPA (fully breastfeeding/amenorrheic vs. -day backup).
Adverse Effects: * Irregular Bleeding: Most common side effect; requires proactive counseling. * General: Headaches, acne, emotional lability, weight increase, depression, site reactions.
Bleeding Management: * Hormonal Treatment: Low-dose or estrogen ( days). * Antifibrinolytic: Tranexamic acid for days. * : days during bleeding episodes. * : Tamoxifen for days.
Emergency Contraception (EC)
Levonorgestrel (LNG) - Plan B One-Step / Next Choice: * Dose: tablet once. * Timing: Use ASAP within days (120 hours). * Efficacy: if within hours; between days . * Repeat Dosing: Repeat if vomited within hours. * Weight Consideration: May lose efficacy in women and lose it completely in women .
Ulipristal Acetate (UPA) - Ella: * Dose: tablet once ( only). * Timing: Maintains high efficacy for the full days. * Repeat Dosing: Repeat if vomited within hours. * Warning: Could harm a fetus; do not use if pregnancy from a previous act is suspected.
Copper IUD (ParaGard): * $> 99\%51317032153A4PPIsH_257> 135140-60FSH50-55COCsVTECOCsBMI > 353517\%3080\%45800\,mcg400\,mcg2-31070200\,mg800\,mcg24-489-168\%> 3075\%$$), weakness, fever, vomiting, headache, diarrhea, and dizziness.